-
EP1248782
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1248782
| EP1248782 - ANTICANCER COMPOUND AND ENANTIOMER SEPARATION METHOD USEFUL FOR SYNTHESIZING SAID COMPOUND [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 30.01.2004 Database last updated on 16.11.2024 | Most recent event Tooltip | 30.01.2004 | Application deemed to be withdrawn | published on 17.03.2004 [2004/12] | Applicant(s) | For all designated states Pfizer Products Inc. Eastern Point Road Groton, CT 06340 / US | [N/P] |
| Former [2002/42] | For all designated states Pfizer Products Inc. Eastern Point Road Groton, Connecticut 06340 / US | Inventor(s) | 01 /
YANG, Bingwei Vera, Pfizer Global Res. & Dev. Eastern Point Road Groton, CT 06340 / US | [2002/42] | Representative(s) | Motion, Keith Robert, et al Pfizer ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR | [N/P] |
| Former [2002/42] | Motion, Keith Robert, et al Pfizer Limited Patents Department Ramsgate Road Sandwich, Kent CT13 9NJ / GB | Application number, filing date | 00976213.9 | 29.11.2000 | [2002/42] | WO2000IB01769 | Priority number, date | US20000177718P | 21.01.2000 Original published format: US 177718 P | [2002/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0153289 | Date: | 26.07.2001 | Language: | EN | [2001/30] | Type: | A1 Application with search report | No.: | EP1248782 | Date: | 16.10.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.07.2001 takes the place of the publication of the European patent application. | [2002/42] | Search report(s) | International search report - published on: | EP | 26.07.2001 | Classification | IPC: | C07D401/14, A61K31/4178, A61P43/00 | [2002/42] | CPC: |
C07D401/14 (EP,US);
A61P13/08 (EP);
A61P17/06 (EP);
A61P31/12 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2002/42] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | ANTIKREBS VERBINDUNG UND ENANTIOMERENTRENNUNGSVERFAHREN ZUR HERSTELLUNG DIESER VERBINDUNG | [2002/42] | English: | ANTICANCER COMPOUND AND ENANTIOMER SEPARATION METHOD USEFUL FOR SYNTHESIZING SAID COMPOUND | [2002/42] | French: | COMPOSE ANTICANCEREUX ET PROCEDE DE SEPARATION D'ENANTIOMERE UTILE POUR SYNTHETISER LEDIT COMPOSE | [2002/42] | Entry into regional phase | 09.07.2002 | National basic fee paid | 09.07.2002 | Designation fee(s) paid | 09.07.2002 | Examination fee paid | Examination procedure | 12.07.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 09.07.2002 | Examination requested [2002/42] | 24.02.2003 | Despatch of a communication from the examining division (Time limit: M06) | 09.09.2003 | Application deemed to be withdrawn, date of legal effect [2004/12] | 15.10.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/12] | Fees paid | Renewal fee | 21.10.2002 | Renewal fee patent year 03 | 24.10.2003 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [DA]WO9716443 (JANSSEN PHARMACEUTICA NV [BE], et al) [DA] 1,5 * page 1, line 38 - page 2, line 1; claim - *; | [DA]WO9721701 (JANSSEN PHARMACEUTICA NV [BE], et al) [DA] 1,5 * page 2, line 4 - line 7; claim - *; | [DPX]WO0047574 (PFIZER PROD INC [US], et al) [DPX] 1,2,5,9* complete document, in particular example 49 and 56 * |